What combinations of mutations help cancer cells survive? Which cells in the brain are involved in the onset of Alzheimer’s? How do immune cells conduct their convoluted
The new technology enables researchers to manipulate gene functions within single cells, and understand the results of each change in extremely high resolution. A single experiment with this method, say the scientists, may be equal to thousands of experiments conducted using previous approaches, and it may advance the field of genetic engineering for medical applications.
The
Amit and his lab team have been developing the second arm of the new method —
Combing CRISPR with the fine resolution of
By linking cells with similar behaviors, something like the algorithms Netflix uses to group people who like similar movies, we were able to identify previously unrated function for many genes
The researchers then faced a new type of data — with quite a few missing values. «By linking cells with similar behaviors, something like the algorithms Netflix uses to group people who like similar movies, we were able to identify previously unrated function for many genes," says Weiner who developed the algorithms to analyze the data.
The combined method enabled the research team to «probe the wiring» of particular mouse immune cells as they combat pathogens. This «proof of principle» experiment identified genes that are important for the function of various immune cells, and illustrated in high resolution how they direct a complex and concentrated response against invading pathogens.
Combining the two methods, say the scientists, can provide new insight that neither method, alone, would be able to yield. The results, says Yofe, can be observed in a resolution never before achieved for this type of study, and these can be obtained more easily and in a fraction of the time. The versatility of the method, combined with the precision the team developed by refining their design through experimentation, suggest that it can be used in the future to investigate many open questions, and produce new results that no one can yet predict.
The results of the research in Amit’s lab were published today in Cell, along with descriptions of two similar technologies developed at the Broad Institute in Boston and the University the California, San Francisco.
«The advent of CRISPR presented a true leap in the ability to understand and start editing immune circuits," says Amit. «We are hoping that our approach will be the next leap forward, providing, among other things, the ability to engineer immune cells for immunotherapy.»
Prof. Ido Amit’s research is supported by the Benoziyo Endowment Fund for the Advancement of Science; the David and Fela Shapell Family Foundation INCPM Fund for Preclinical Studies; the Leona M. and Harry B. Helmsley Charitable Trust; the Rosenwasser Fund for Biomedical Research; the Alan and Laraine Fischer Foundation; Isa Lior, Israel; Drs. Herbert and Esther Hecht, Beverly Hills, CA; the Comisaroff Family Trust; Rising Tide; the David M. Polen Charitable Trust; the BLG Trust; and Mr. and Mrs. Harold Hirshberg, Park Ridge, NJ. Prof. Amit is the recipient of the Helen and Martin Kimmel Award for Innovative Investigation.
Source: http://wis-wander.weizmann.ac.il/life-sciences/gene-editing-takes-new-roles